Andre Zagorski is senior principal technical advisor in MSH’s Pharmaceuticals and Health Technologies (PHT) Group, in charge of developing TB strategies and interventions to ensure universal access to anti-TB medicines, regimens and new technologies in line with the USAID and WHO goals of ending the TB epidemic.
Dr. Javier Guzman is MSH’s Technical Director of the USAID-funded MTaPS Project. Javier has worked in public health policy and practice for 17 years as a physician, researcher, analyst, and policymaker...
Judith Seltzer is the Senior Director of the Performance, Learning and Impact unit at MSH. In this capacity, she leads a team of diverse specialists who provide knowledge management, research, and monitoring and evaluation support across the organization.
Floride Niyuhire, MD, MPH, is a seasoned leader with more than 20 years of public health experience in Africa, ranging from hospital-based medical practice to policy formulation and implementation throughout decentralized systems.
Colin Gilmartin serves as a Senior Technical Advisor for Health Economics and Financing at Management Sciences for Health. In this role, he supports the design and implementation of programs and initiatives to advance universal health coverage with a focus on policy research and analysis, economic evaluation and financial modeling, and program management.
David Collins is a Chartered Accountant with over 30 years of experience in international health and development projects, including working as resident health finance advisor to the Ministries of Health of Kenya and South Africa. He works for Management Sciences for Health in health financing and teaches health finance at Boston University.
Senior Technical Director of Pharmaceutical Economics and Financing
Héctor Castro, MD, Senior Technical Director of Pharmaceutical Economics and Financing at MSH, has nearly 20 years of global health experience with a focus on health systems strengthening in quality assurance, assessment, health financing, strategic purchasing, and provision of health care technologies (including medicines, devices, and procedures).
Zana C. Somda, PhD, has more than 20 years of international development experience in the fields of agriculture and health systems strengthening, with a focus on health financing, costing, cost-effectiveness studies, economic evaluation, and monitoring and evaluation, especially in sub-Saharan Africa. In his role at MSH, he guides and supports business development and program implementation with a focus on health systems strengthening; health financing; pharmaceutical economics; and health technology assessment, training, and capacity building in support of project activities and deliverables.
Ritu Kumar is the practice area lead for MSH's work on Health Technology Assessment (HTA) and Market Dynamics. She provides technical expertise to various projects on establishing systematic priority setting and health technology assessment mechanisms, scaling up access to new health technologies, medicines pricing, and strategic purchasing approaches...